Clinical Trials Logo

Major Depression Disorder clinical trials

View clinical trials related to Major Depression Disorder.

Filter by:
  • None
  • Page 1

NCT ID: NCT06278038 Recruiting - Clinical trials for Major Depression Disorder

Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder

Start date: February 22, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of toludesvenlafaxine hydrochloride sustained-release tablets in the treatment of major depression disorder compared to venlafaxine hydrochloride sustained-release tablets, to provide evidence-based basis for clinical rational drug use.

NCT ID: NCT05597566 Recruiting - Clinical trials for Major Depression Disorder

Predictive Effect of Neuroinflammatory Factors of the MECT in Treatment of Senile Depression

Start date: June 1, 2021
Phase:
Study type: Observational

To compare the correlation between the clinical efficacy of MECT treatment and baseline, 3 times, 8 times of treatment, 1 week after treatment, and 2 weeks after treatment in patients with depression and suicidal ideation. The prediction effect of -1β and IL-6 levels and level changes on the efficacy of MECT in the treatment of suicidal ideation in elderly patients with depression, and provide a theoretical basis for further research on the mechanism of MECT in the treatment of elderly depression with suicidal ideation.

NCT ID: NCT02773108 Completed - Schizophrenia Clinical Trials

Somatic Comorbidities in Psychiatric Patients

SCPP
Start date: May 2016
Phase:
Study type: Observational

Prevalence of somatic comorbidities in psychiatric patients hospitalized in Psychiatric hospital or treated ambulatory or in daily hospital. Comparison of prevalence of somatic comorbidities in psychiatric patients population and the general Croatian population.

NCT ID: NCT02400346 Completed - Clinical trials for Major Depression Disorder

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

Start date: March 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of brexpiprazole as adjunctive treatment in an elderly population with major depressive disorder and an inadequate response to antidepressant treatment

NCT ID: NCT02273154 Recruiting - Clinical trials for Major Depression Disorder

Randomized,Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder

Start date: August 2014
Phase: Phase 4
Study type: Interventional

This is a Multicenter, open lable, parallel randomized controlled clinical trial. This study aimed to evaluate the treatment onset time, efficacy and safety in patients with major depressive disorders , accompanying anxiety receiving Buspirone and Paroxetine.